UNSPSC 85882720: Tomographic (tomo) nuclear medicine imaging of lower extremity using iodine 123 (i-123)

This classification denotes the group of activities that yields an intervention or procedure of tomographic (tomo) nuclear medicine imaging of lower extremity using iodine 123 (i-123). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code CW2DFZZ

UNSPSC 85882720 Tomographic (tomo) nuclear medicine imaging of lower extremity using iodine 123 (i-123), a Commodity code, shows no recent state and local procurement activity aligned to its specific scope. The three most recent opportunities tagged under this code—a diagnostic imaging PACS system implementation at San Mateo Medical Center (RFP, due October 21, 2026), special education contracted services at Birdville Independent School District in Texas (RFP, due October 21, 2026), and temporary health professional staffing for Santa Clara County Health System (RFQ for multiple ancillary clinical categories, due October 7, 2026)—represent procurement of imaging infrastructure, educational support services, and temporary clinical staffing respectively, none of which directly map to tomographic nuclear medicine imaging with iodine-123 isotope protocols for lower extremity vascular or perfusion studies. The San Mateo PACS solicitation encompasses enterprise imaging system selection and migration, the school district opportunity covers on-call special education evaluators and therapists, and the Santa Clara posting establishes a qualified vendor pool for temporary radiology technicians and other clinical staff—all distinct from radiopharmaceutical imaging services or specialized nuclear medicine procedures.

The tagging mismatch suggests this Commodity code either sees minimal current demand or is applied inconsistently by issuing bodies in state and local procurement systems. Business development professionals evaluating this code should verify whether opportunities are genuinely present in the underlying procurement databases or whether recent activity reflects data classification error rather than authentic market demand for nuclear medicine imaging services under this specific isotope and anatomical focus.